A carregar...

Latrepirdine, a potential novel treatment for Alzheimer’s disease and Huntington’s chorea

Latrepirdine (Dimebon) is a novel compound currently under development by Medivation Inc and Pfizer Inc for the treatment of Alzheimer’s disease and Huntington’s chorea. Originally developed and marketed as an antihistamine in Russia, it has potential for the treatment of neurodegenerative diseases....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sabbagh, Marwan N, Shill, Holly A
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3346261/
https://ncbi.nlm.nih.gov/pubmed/20047162
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!